share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 YOUNG JAMES F
美股SEC公告 ·  06/26 04:18

Moomoo AI 已提取核心訊息

James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
諾瓦瓦克斯醫藥公司[NVAX]的詹姆斯·F·揚在2024年6月21日完成了對7500股普通股的出售。這筆交易在公開市場上進行,每股售價爲14.09美元,總售價爲105,675美元。銷售後,揚在諾瓦瓦克斯普通股中的直接持股數量爲61,760股。
諾瓦瓦克斯醫藥公司[NVAX]的詹姆斯·F·揚在2024年6月21日完成了對7500股普通股的出售。這筆交易在公開市場上進行,每股售價爲14.09美元,總售價爲105,675美元。銷售後,揚在諾瓦瓦克斯普通股中的直接持股數量爲61,760股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息